Atrazine represses S100A4 gene expression and TPA-induced motility in HepG2 cells - ToxAlim Accéder directement au contenu
Article Dans Une Revue Toxicology in Vitro Année : 2014

Atrazine represses S100A4 gene expression and TPA-induced motility in HepG2 cells

Ludovic Peyre
  • Fonction : Auteur
Nathalie Zucchini-Pascal
  • Fonction : Auteur
Roger Rahmani
  • Fonction : Auteur

Résumé

Atrazine (ATZ) is probably the most widely used herbicide in the world. However there are still many controversies regarding its impacts on human health. Our investigations on the role of pesticides in liver dysfunctions have led us to detect an inhibition of FSPI expression of 70% at 50 mu m and around 95% at 500 mu M of ATZ (p <0.01). This gene encodes the protein S100a4 and is a clinical biomarker of epithelial-mesenchymal transition (EMT), a key step in the metastatic process. Here we investigated the possible effect of ATZ on cell migration and noticed that it prevents the EMT and motility of the HepG2 cells induced by the phorbol ester TPA. ATZ decreases Fak pathway activation but has no effect on the Erk1/2 pathway known to be involved in metastasis in this cell line. These results suggest that ATZ could be involved in cell homeostasis perturbation, potentially through a S100a4-dependant mechanism. (C) 2013 Elsevier Ltd. All rights reserved.
Fichier non déposé

Dates et versions

hal-02630331 , version 1 (27-05-2020)

Identifiants

Citer

Ludovic Peyre, Nathalie Zucchini-Pascal, Roger Rahmani. Atrazine represses S100A4 gene expression and TPA-induced motility in HepG2 cells. Toxicology in Vitro, 2014, 28 (2), pp.156 - 163. ⟨10.1016/j.tiv.2013.10.019⟩. ⟨hal-02630331⟩
8 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More